The mission of LNBio’s Facilities and Services Division is to promote scientific and technological excellence by providing strategic reference laboratories, supporting CNPEM researchers and the external academic community in innovative projects. This division plays a fundamental role in executing, refining, and developing new technologies, expanding laboratory infrastructure, and encouraging research innovation.
With a new modern equipment complex, it directly supports the Center’s lines of activity. Highlights include laboratories specializing in bioassays, advanced omics and biomolecules, such as the Automated Protein Crystallization Laboratory (ROBOLAB), which collaborate with the X-ray diffraction technique on the Manacá beamline at Sirius, and bioimaging, like the Biological Imaging Laboratory (LIB), which uses advanced technologies in collaboration with Sirius and LNNano. Together, these labs drive cutting-edge discoveries and consolidate an ecosystem of collaborative, open and transformative science.
Advanced methodologies have revolutionized our understanding of biological processes in health and in illnesses, offering new opportunities for early diagnosis, to develop personalized therapies, and to discover prognostic biomarkers
The group’s objective is to test technology and expertise to evaluate the structure and activity of proteins and their interactions with small molecules (pharmaceuticals and drugs) or macromolecules (DNA, RNA, and carbohydrates), making it possible to identify modifications in metabolic profiles and potential alterations in metabolic pathways
Group specializing in the synthesis of peptides and DNA and RNA oligonucleotides, as well as the purification, characterization and crystallization of proteins and their complexes. Consists of four open facilities with state-of-the-art technology, modern equipment and highly qualified staff to support a wide range of scientific projects. Combines expertise in the chemical synthesis of biomolecules, as well as in the biophysical, functional and structural characterization of proteins and the study of their interactions. This integration between knowledge and technology allows the scientific community to carry out innovative research, driving discoveries and studies that benefit various areas of knowledge
Expanding the understanding of diseases, identifying molecular targets for personalized therapies, and translating discoveries into health benefits
Expanding our understanding of the mechanisms of viral and bacterial illnesses and those that affect neglected populations, such as Chagas disease
Acting as a catalyst and carrying out complex tasks, transforming scientific knowledge into technologies for Brazilian healthcare
Enables radical innovation in pharmaceuticals in Brazil through the sustainable use of biodiversity in connection with cutting-edge science and high technology